Research Paper Volume 15, Issue 10 pp 4122—4143
PCNT is a prognostic biomarker correlated with tumor immune microenvironment in hepatocellular carcinoma and promotes tumor progression by inhibiting cell cycle arrest
Figure 7. (A) The associations between PCNT and immune checkpoint inhibitor-related gene expression levels. (B–J) HCC tissues with higher PCNT expression have a higher level of VEGFB (B), VTCN1 (C), CD274 (D), IL13 (E), IL12A (F) HAVCR2 (G), VEGFA (H), ADORA2A (I), and CD276 (J) expression. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.